The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
The Danish Warfarin-Dialysis Study: Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis - A Nationwide Parallel-group Open Randomized Clinical Trial
Nábor prebieha
• Fáza 4 • intervenčná • NCT03862859
Stručný súhrn
The study aims to evaluate the appropriateness of initiating oral anticoagulation for stroke risk reduction in dialysis populations with atrial fibrillation. Specifically, the study will assess the overall safety, tolerability, and efficacy of initiating treatment with Warfarin in patients with end-stage renal disease on dialysis and atrial fibrillation.
Základné údaje
| Ochorenia | Atrial Fibrillation and Flutter, Stroke, Major Bleed, End-stage Renal Disease |
|---|---|
| Intervencie | DRUG: Warfarin |
| Sponzor | Nicholas Carlson |
| Plánovaný počet | 718 |
| Začiatok | 2019-10-09 |
| Predp. ukončenie (primárne) | 2027-01-01 |
| Krajiny | Denmark |
| Posledná aktualizácia | 2026-05-19 |
Upozornenie: údaje sú orientačné a podliehajú zmenám. Úplné vstupné/vylučovacie
kritériá, kontakty a aktuálny stav nájdete v oficiálnom registri. Tento prehľad
nenahrádza lekársku konzultáciu.